Congratulations! Great Bay Bio Was Approved to Establish a Guangdong Doctoral Workstation

Created on:2020-08-05 14:22

logo

August 5th,2020 Press Release

Congratulations! Great Bay Bio Was Approved to Establish a Guangdong Doctoral Workstation

[2020/8/5, Dongguan] Recently, Human Resources and Social Security Department of Guangdong Province has announced to approve Dongguan Taili Biotech Co., Ltd., a subsidiary of Great Bay Bio to establish a Guangdong doctoral workstation.

Great Bay Bio has always been committed to provide broad and free stage for capable talents, introduce high-level talents, and support talent development in all aspects to build a high-tech talent team featured in moderate scale, reasonable structure, high quality, innovation, and dynamism.

Taking the opportunity of establishing a doctoral workstation, Great Bay Bio will respond to the government’s talent policy, give an impetus to related industries and areas, improve its overall team quality, and better conduct its work concerning biotechnology service and biologics development.

 

The Guangdong doctoral workstation represents a new exploration according to the government paper Certain Opinions of Accelerating the Innovative Development of Doctoral and Post-Doctoral Talents in the New Era, with a leading position in the whole country.

 

About Great Bay Bio

Headquartered in Hong Kong, GBB is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to CMC (Chemistry, Manufacturing, Control) for development of biopharmaceuticals and other blue ocean bio-products (such as cell therapy), ultimately solving numerous pain points of CMC development, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has obtained massive data from conventional biologics development in its 3100 m2 CMC facilities in Dongguan, PRC. With over RMB 300M investment, the facilities bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created the intelligent centralized database, where deep learning is being performed to create next generation AI-enabled CMC platforms. To learn more, please visit http://www.greatbay-bio.com.

 

PR Contact: Miss Liu 

Email: yt.liu@greatbay-bio.co

Home    News    Congratulations! Great Bay Bio Was Approved to Establish a Guangdong Doctoral Workstation
PV:0
Collect